Anticoagulant and disease-modifying therapy for atrial fibrillation and heart failure in certain Russian regions in 2023

Anticoagulant and disease-modifying therapy for atrial fibrillation and heart failure in certain Russian regions in 2023

Aim. Retrospective analysis of the prescription rate of anticoagulant and disease-modifying therapy (DMT) to patients with atrial fibrillation (AF) and heart failure (HF) in certain Russian regions as of December 31, 2023.Material and methods. A group of patients with AF and HF (n=7901, men 51,1%,...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. A. Druzhilov, O. Yu. Druzhilova, T. Yu. Kuznetsova, D. V. Gavrilov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2025-05-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	atrial fibrillation heart failure anticoagulant therapy disease-modifying therapy retrospective analysis
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/4327
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Problematic points of anticoagulant therapy for atrial fibrillation in certain Russian regions in 2016- 2019: results of a retrospective big data analysis
by: M. A. Druzhilov, et al.
Published: (2024-10-01)

Clinical characteristics and frequency of anticoagulation in patients with atrial fibrillation and heart failure: results of a retrospective big data analysis
by: M. A. Druzhilov, et al.
Published: (2023-03-01)

Retrospective analysis of the prevalence of ischemic stroke and the appointment of anticoagulant therapy in patients with atrial fibrillation depending on the body mass index
by: M. A. Druzhilov, et al.
Published: (2023-06-01)

Patients with atrial fibrillation and a low risk of thromboembolic events: prescription rate of anticoagulant therapy according to a retrospective analysis
by: M. A. Druzhilov, et al.
Published: (2023-09-01)

Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice
by: Yu. P. Skirdenko, et al.
Published: (2022-03-01)

Atrial fibrillation and chronic kidney disease: main clinical characteristics of patients in selected subjects of the Russian Federation
by: M. A. Druzhilov, et al.
Published: (2023-05-01)

Factors determining adherence to anticoagulant therapy in patients with atrial fibrillation
by: D. V. Pevzner, et al.
Published: (2023-06-01)

Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter
by: M. V. Serova, et al.
Published: (2021-09-01)

Atrial fibrillation in the elderly and long-livers: a retrospective analysis of the clinical profile of patients using artificial intelligence
by: M. A. Druzhilov, et al.
Published: (2023-09-01)

COMPARISON OF SCHEMES OF PERIOPERATIONAL ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS DEMANDING FOR SURGERY
by: L. N. Uddin, et al.
Published: (2018-06-01)

Anticoagulant therapy in patients with cardioembolic subtype of ischemic stroke and atrial fibrillation
by: E. A. Naryshkina, et al.
Published: (2025-06-01)

The use of oral anticoagulants in patients with atrial fibrillation: cohort study data
by: O. V. Gaisenok, et al.
Published: (2016-09-01)

Anticoagulant therapy in patients with atrial fibrillation and an implanted cardiac resynchronization therapy device
by: M. A. Kirgizova, et al.
Published: (2021-05-01)

Bleeding and Thrombotic Events in Hemodialysis Patients with Atrial Fibrillation on Anticoagulation and Antiplatelet Therapy: A 24-Month Cohort Study
by: Zorica M. Dimitrijevic, et al.
Published: (2024-10-01)

Anticoagulation Therapy for Atrial Fibrillation After Transcatheter Aortic Valve Replacement: National Database Insights
by: Koki Takegawa, et al.
Published: (2025-07-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01)

State and adequacy of anticoagulant therapy in fibrillation of precurities in clinical practice
by: A. A. Tuchkov, et al.
Published: (2021-06-01)

Inappropriate dosing of direct oral anticoagulants among very older inpatients with atrial fibrillation
by: Ya-Tong Zhang, et al.
Published: (2025-04-01)

ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT
by: E. L. Dolgova, et al.
Published: (2015-09-01)

Hypertension, chronic kidney disease, atrial fibrillation and the newer anticoagulants
by: B. Rayner
Published: (2012-10-01)

Clinical and pathogenetic characteristics and management of patients with atrial fibrillation in a cardiology department at the present time
by: V. K. Kurashin, et al.
Published: (2020-07-01)

THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER
by: S. Y. Martsevich, et al.
Published: (2015-09-01)

CURRENT PRINCIPLES AND TRENDS OF ATRIAL FIBRILLATION PHARMACOTHERAPY
by: Yu. A. Bunin
Published: (2016-01-01)

FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW
by: S. A. Zenin, et al.
Published: (2015-09-01)

Anticoagulant therapy control in primary healthcare setting
by: Z. K. Salpagarova, et al.
Published: (2016-06-01)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
by: M. Yu. Gilyarov
Published: (2015-12-01)

THE OPPORTUNITIES FOR RISK REDUCTION OF RECURRENT STROKE IN ATRIAL FIBRILLATION
by: I. L. Davydkin, et al.
Published: (2015-06-01)

Recurrent bleeding during standard anticoagulant therapy in comorbid patients with atrial fibrillation: a clinical case report
by: A. A. Kudriavtseva, et al.
Published: (2023-07-01)

A patient with atrial fibrillation and diabetes: selecting the optimal anticoagulant therapy regimen
by: A. G. Obrezan, et al.
Published: (2021-06-01)

Prospects of oral anticoagulant therapy in patients with atrial fibrillation and chronic anemia: a narrative review
by: Tatyana S. Degtyareva, et al.
Published: (2024-12-01)

Approaches to anticoagulation therapy selection in patients with non-valvular atrial fibrillation and ischemic heart disease
by: N. A. Koziolova, et al.
Published: (2016-04-01)

NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
by: D. A. Itkin, et al.
Published: (2015-02-01)

THE ENDOVASCULAR PREVENTION OF THROMBOEMBOLISM IN ATRIAL FIBRILLATION
by: Rami N. Al-Ayyubi, et al.
Published: (2018-12-01)

Anticoagulation for Stroke Prevention in Patients with Atrial Fibrillation: A Review of the Literature and Current Guidelines
by: Vrinda Vyas, et al.
Published: (2025-06-01)

Atrial fibrillation with thrombotic complications. Justification of the diagnosis and treatment regimen according to evidence-based medicine (clinical case)
by: L.O. Martymianova, et al.
Published: (2024-12-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01)

Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01)

Contribution of anticoagulant therapy adherence to the risk of complications of atrial fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2019-03-01)

Features of Thromboembolic and Hemorrhagic Complications in Planned Surgical Interventions in Patients with Atrial Fibrillation
by: L. N. Uddin, et al.
Published: (2019-07-01)

PHARMACODYNAMICS OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ACUTE PERIOD OF ISCHEMIC STROKE
by: V. I. Petrov, et al.
Published: (2021-01-01)